Phase 4 HIV-1 Clinical Trials
4 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–4 of 4 trials
Recruiting
Phase 4
A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments
HIV-1-infection
Gilead Sciences350 enrolled14 locationsNCT06337032
Recruiting
Phase 4
Switch to Dolutegravir Plus Lamivudine Dual-Therapy in Transgender Women Living With HIV on Virologically Suppressive Antiretroviral Therapy (TRANS-SWITCH)
HIVHIV-1
UBATEC50 enrolled1 locationNCT06967753
Recruiting
Phase 4
Long Acting Cabotegravir Plus Rilpivirine in People Living with HIV-1 Aged ≥ 60 Years for 24 Months.
HIV-1 Infected Adults with Controlled Viremia
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia120 enrolled8 locationsNCT06646562
Recruiting
Phase 4
2DR Versus 3DR in a Prospective Randomized Controlled Switch Trial
HIV-1-infection
University Hospital, Ghent134 enrolled1 locationNCT04553081